Amryt Pharma (NASDAQ:AMYT) reported its Q4 earnings results on Wednesday, March 9, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Amryt Pharma beat estimated earnings by 53.33%, reporting an EPS of $-0.07 versus an estimate of $-0.15.
Revenue was up $12.31 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.1 which was followed by a 6.67% increase in the share price the next day.
Here's a look at Amryt Pharma's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.17 | 0.19 | 0.13 | -0.34 |
| EPS Actual | -0.07 | -0.04 | -0.09 | -0.28 |
| Revenue Estimate | 52.78M | 50.49M | 46.15M | 41.97M |
| Revenue Actual | 56.52M | 62.76M | 48.43M | 42.52M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
